期 |
标题 |
文件 |
卷 52, 编号 2 (2018) |
Huatanjiangqi Capsule Upregulating NRF2 and MRP1 Expression in Chronic Obstructive Pulmonary Disease in Rats |
|
Xu X., Chen Y., Zhang M., Wang D., Wu J., Yao Z., Wu Q., Fang W.
|
卷 49, 编号 10 (2016) |
Human Serum Albumin Interactions with Bioactive 3H-Imidazo[4,5-A]Acridin-11(6H)-Ones Studied by Fluorescence Spectroscopy |
|
Tavanaei P., Pordel M., Chamani J.
|
卷 52, 编号 2 (2018) |
Hydrogel Nanoparticles of Chitosan—Folic-Acid Conjugate with Imatinib Methanesulfonate |
|
Lozovskaya M., Kulikovskaya V., Ignatovich Z., Koroleva E., Agabekov V.
|
卷 51, 编号 12 (2018) |
Hydrophobic Constituents Extracted from Chaga by Ethylacetate |
|
Kyyamova G., Khabibrakhmanova V., Sysoeva M.
|
卷 53, 编号 3 (2019) |
Hypolipidemic Action of Medicinal Plant Extracts for Experimental Diabetes Mellitus |
|
Vengerovskii A., Yakimova T., Nasanova O.
|
卷 50, 编号 7 (2016) |
Identification of Flavonoids in Homeopathic Mother Tinctures of Galanthus woronowii Losinsk. And Galanthus nivalis L. by Ultra-Performance Liquid Chromatography with Photodiode Arrays and Tandem Quadrupole Mass-Selective Detectors |
|
Bokov D., Samylina I.
|
卷 52, 编号 5 (2018) |
Immobilization of Benzocaine in Polymeric Nanocontainers. Pharmacokinetic Modeling |
|
Shkurenko G., Lyrshchikov S., Gorlov A., Al’tshuler O., Al’tshuler G.
|
卷 51, 编号 5 (2017) |
Immunomodulating Activity of Extract of Gentiana Algida Pall. |
|
Khobrakova V., Budaeva E., Olennikov D., Zilfikarov I.
|
卷 53, 编号 3 (2019) |
Improved Process for Zoledronic Acid Synthesis |
|
Kuvaeva Z., Lopatik D., Bondareva O.
|
卷 50, 编号 2 (2016) |
Improved Voriconazole Topical Delivery by Nanoparticles (Minireview) |
|
Nassiri-Kashani M., Namdar R., Nafisi S., Maibach H.
|
卷 50, 编号 3 (2016) |
Improving Pharmaceutical Characteristics of Curcumin by Alginate/Pectin Microparticles |
|
Sattarahmady N., Moosavi-Movahedi A., Bazzi P., Heli H., Pourtakdoust S.
|
卷 53, 编号 5 (2019) |
Influence of Filipendula ulmaria (L.) Maxim. Extract on Lewis Lung Carcinoma Development and Cytostatic Therapy Effectiveness in Mice |
|
Amosova E., Shilova I., Zueva E., Rybalkina O.
|
卷 53, 编号 5 (2019) |
Influence of Lychnis chalcedonica L. Flavonoids on Transplanted Tumor Development and Cytostatic Therapy Effectiveness in Mice |
|
Amosova E., Zueva E., Lopatina K., Safonova E., Razina T., Rybalkina O., Zibareva L.
|
卷 49, 编号 11 (2016) |
Influence of N,N′-Substituted Piperazines on Cytolysis |
|
Veselkina O., Solovtsova I., Petrishchev N., Galebskaya L., Borovitov M., Nilov D., Solov’eva M., Vorob’ev E., Len’shina K.
|
卷 51, 编号 5 (2017) |
Influence of Human Biorhythms on the Blood Glucose Level and the Efficacy of Hypoglycemic Drugs (Review) |
|
Bunyatyan N., Bukhtiyarova I., Drogovoz S., Kononenko A., Olefir Y., Prokof’ev A., Proskurina I., Goryachev D.
|
卷 50, 编号 3 (2016) |
Influence of Melatonin-Correcting Drugs (Melaxen and Valdoxan) on the Levels of Superoxide Dismutase and Catalase Gene Transcription in Rats with Experimental Hyperthyroidism |
|
Popova T., Agarkov A., Gorbenko M., Popov S., Shul’gin K.
|
卷 52, 编号 8 (2018) |
Influence of New Promising Analgesic Compounds on Locomotor Activity of Mice |
|
Palikova Y., Skobtsova L., Zharmukhamedova T., Palikov V., Rudenko V., Khokhlova O., Lobanov A., Rzhevskii D., Slashcheva G., D’yachenko E., Belous G., Andreev Y., Logashina Y., Kozlov S., Yavorskii A., Elyakova E., D’yachenko I.
|
卷 50, 编号 10 (2017) |
Influence of Polyuronides on Biological Oxidation, Liver Antitoxic Functions, and Erythrocyte Membrane Condition in Lead-Intoxicated Rats |
|
Kaisheva N., Vasilenko Y., Kaishev A.
|
卷 52, 编号 9 (2018) |
Influence of Various Disintegrants on the Quality of Microcrystalline Cellulose Tablets |
|
Demina N., Bobkova N., Solodun E., Anurova M., Bakhrushina E., Krasnyuk I.
|
卷 53, 编号 2 (2019) |
Inhibition of α-Amylase and α-Glucosidase by New β-Aminopropionamidoxime Derivatives |
|
Kayukova L., Uzakova A., Baitursynova G., Dyusembaeva G., Shul’gau Z., Gulyaev A., Sergazy S.
|
卷 51, 编号 11 (2018) |
Inhibitory Effect of Excoecaria Agallocha L. Extracts on Elastase and Collagenase and Identification of Metabolites Using HPLC-UV-MS Techniques |
|
Satyavani K., Gurudeeban S., Ramanathan T.
|
卷 53, 编号 4 (2019) |
Insulin Preparation for Blood Glucose-Level Regulation |
|
Valuev I., Starosel’tseva L., Valuev L., Vanchugova L.
|
卷 50, 编号 10 (2017) |
Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian Federation |
|
Kocherovets V., Bunyatyan N., Olefir Y., Alyautdin R., Romanov B., Prokof’ev A.
|
卷 51, 编号 11 (2018) |
Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example |
|
Bunyatyan N., Filippova O., Romanov B., Prokof’ev A.
|
卷 51, 编号 8 (2017) |
Interchangeability Problems of Drugs with Narrow Therapeutic Indices |
|
Zatolochina K., Pasternak E., Alyautdin R., Snegireva I., Romanov B., Polivanov V., Olefir Y.
|
卷 52, 编号 7 (2018) |
Inulin-Like Fructosan Content in the Below-Ground Organs of Echinacea purpurea and Its Processing Products |
|
Babaeva E., Zvereva V., Semkina O.
|
卷 53, 编号 8 (2019) |
Investigation Planning and Bioequivalence evaluation of Angiotensin II Receptor Antagonists |
|
Romodanovskii D., Goryachev D., Khokhlov A., Miroshnikov A.
|
卷 53, 编号 2 (2019) |
Iron-Binding and Iron-Reducing Properties of Material Based on Collagen and Taxifolin (Dihydroquercetin) Under Physiological and Pathophysiological Conditions |
|
Shatalin Y., Shubina V.
|
卷 51, 编号 3 (2017) |
Isolation and Characterization of Bioactive Phenolic Compounds from Abies Pindrow Aerial Parts |
|
Kumar D., Kumar S.
|
卷 52, 编号 6 (2018) |
Isolation of Anaerobic Bacteria During Quality Analysis of Medicinal Products |
|
Sakhno N., Gunar O., Roshchina M., Kolosova L., Grigor’eva V.
|
卷 51, 编号 6 (2017) |
Isolation of Peptides from Calf Brain Tissue and Evaluation of their Tissue-Specific and Stimulatory Activity |
|
Chernova I., Zhilinskii D., Chalisova N., Shataeva L.
|
卷 50, 编号 6 (2016) |
Issues Related to Patent Protecton of Darunavir and its Analogs |
|
Goizman M., Zotova O., Kamalova A., Popova A., Shobolov D., Korlyukov A., Suponitskii K., Shimanovskii N., Zaitsev S., Degterev E.
|
卷 52, 编号 12 (2019) |
Joint Mechanical Processing of a Drug Substance with Enterosorbent |
|
Ivanova N., Pak T., Kristalovich É., Takhtaganova D.
|
卷 51, 编号 6 (2017) |
Kilogram-Scale Pilot Synthesis of Fingolimod |
|
Balaev A., Busel A., Fedorov V.
|
卷 50, 编号 7 (2016) |
Kinetics of Ibuprofen Release From Magnetic Nanoparticles Coated with Chitosan, Peg and Dextran |
|
Gronczewska E., Defort A., Kozioł J.
|
卷 52, 编号 10 (2019) |
Kinetics of One-Step Mepivacaine Synthesis on Polymers Containing Pd-Nanoparticles |
|
Abdullaev M.
|
卷 51, 编号 11 (2018) |
L-Arginine – Cellulose-Acetate-Sulfate Complex and its Influence on Endothelial Dysfunction in Rats |
|
Shakhno E., Savitskaya T., Grinshpan D., Pokrovskaya T., Yakushev V., Pokrovskii M.
|
卷 51, 编号 1 (2017) |
LC Method Development and Validation for the Determination of Ropivacaine Hydrochloride in Bulk Drug and Pharmaceutical Formulations |
|
Chigurupati S., Appala R., Selvarajan K., Khaw C., Teoh C., Batumanathan L., Mohammad J.
|
卷 51, 编号 6 (2017) |
Limit of Detection of Microorganisms in Drug Sterility Testing |
|
Roshchina M., Gunar O., Sakhno N.
|
卷 50, 编号 11 (2017) |
Lipids and Lipophilic Constituents of Comfrey (Symphytum Officinale L.) Seeds |
|
Yunusova S., Lyashenko S., Fedorov N., Yunusov M., Denisenko O.
|
卷 52, 编号 8 (2018) |
Local Analgesic Activity of Hemantane Gel Dosage Forms Evaluated Using the Formalin Test in Rats |
|
Ivanova E., Matyushkin A., Blynskaya E., Voronina T.
|
卷 50, 编号 9 (2016) |
Local Anesthetic Activity of a Promising Piperidine Derivative (LAS-54) in Combination with Epinephrine |
|
Pichkhadze G., Smagulova G., Kadyrova D., Praliev K., Yu V.
|
卷 53, 编号 2 (2019) |
Lupeol from Nyctanthes arbor-tristis Inhibits Matrix Metalloproteinase Activity, Angiogenesis and Proliferation of Glioma Cells |
|
Ashwini P., Rekha P.
|
卷 51, 编号 4 (2017) |
Lyophilization as a Method for Stabilizing Pharmaceuticals |
|
Nikolaeva L., Gulyakin I., Orlova O., Polozkova A., Oborotova N., Sanarova E., Lantsova A., Khlamov V., Bunyatyan N.
|
卷 53, 编号 9 (2019) |
Main Aspects of Pharmaceutical Gel Development for Peroral Administration |
|
Bakhrushina E., Anurova M., Demina N., Ivannikov G.
|
卷 52, 编号 7 (2018) |
Mechanical and Physical-Technological Properties of Gelatin Ribbon in the Manufacture of Soft Gelatin Capsules |
|
Molokhova E., Ponomareva E., Adamov A., Kholov A.
|
卷 50, 编号 6 (2016) |
Mechanisms of Antiradical Activity of 2,3,5,6,8-Pentahydroxy-7-Ethyl-1,4-Naphthoquinone (A Review) |
|
Talalaeva O., Zverev Y., Bryukhanov V.
|
卷 53, 编号 5 (2019) |
Metal-Based Molecular Compounds: Structure, Analytical Properties, dsDNA Binding Studies and In Vitro Antiproliferative Activity on Selected Cancer Cell Lines |
|
Çeşme M., Gölcü A.
|
卷 52, 编号 3 (2018) |
Method Development and Stress Degradation Profile of 5-Benzyl-1,3,4-Oxadiazole-2-Thiol Studied by UV Spectroscopy |
|
Qamar S., Hussain K., Bukhari N., Shehzadi N., Islam M., Siddique S., Aziz-ur-Rehman .
|
卷 53, 编号 3 (2019) |
Method Development for Determining Prekallikrein Activator in Medicinal Preparations of Human Immunoglobulins and Albumin |
|
Kornilova O., Krivykh M., Konovalova E., Borisevich I.
|
卷 51, 编号 10 (2018) |
Method Development for Quantitative Determination of Ascorbic Acid by High-Performance Thin-Layer Chromatography |
|
Trineeva O., Safonova E., Slivkin A.
|
卷 49, 编号 12 (2016) |
Method Development for Quantitative Determination of Ormustine in Biological Fluids by High Performance Liquid Chromatography with Mass-Spectrometric Detection |
|
Pyataev N., Petrov P., Burtasov A., Minaeva O., Kulikov O., Gurevich K., Zaborovskii A., Krasnov V., Kokorev A., Stolyarov G., Zyrnyaeva N.
|
卷 50, 编号 9 (2016) |
Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs |
|
Krivykh M., Kornilova O., Bunyatyan N., Paramonova E., Volkova R., Fadeikina O.
|
卷 52, 编号 6 (2018) |
Methods for Analytical Control of Darunavir Tablet Dosage Forms. Part II |
|
Goizman M., Shimanovskii N., Shobolov D., Zotova O., Ermakova O., Tikhomirova G., Chernobrovkin M.
|
卷 52, 编号 11 (2019) |
Methods of Microbial Identification During Drug Quality Analysis and Applicability Assessment |
|
Gunar O., Sakhno N.
|
卷 50, 编号 2 (2016) |
Microbiological Quality Control of Biotechnological Pharmaceuticals |
|
Gunar O., Builova I.
|
卷 52, 编号 12 (2019) |
Microcolumn HPLC-UV Analysis of Glycyrrhiza Uralensis and Licorice Preparations |
|
Vennos C., Olennikov D., Zilfikarov I.
|
卷 52, 编号 6 (2018) |
Microemulsions as Potential Bases for Formulating Modern Transdermal Therapeutics |
|
Gil’deeva G., Yurkov V.
|
卷 51, 编号 6 (2017) |
Microencapsulation of Imatinib Methanesulfonate |
|
Ignatovich Z., Golubeva M., Koroleva E., Agabekov V., Gilevskaya K.
|
卷 52, 编号 5 (2018) |
Microwave-Assisted Synthesis, In Vivo Anti-Inflammatory and In Vitro Anti-Oxidant Activities, and Molecular Docking Study of New Substituted Schiff Base Derivatives |
|
Hanif M., Hassan M., Rafiq M., Abbas Q., Ishaq A., Shahzadi S., Seo S., Saleem M.
|
卷 53, 编号 5 (2019) |
Modeling the Desorption Stage in Lyophilization Technology of bis(N-Monosuccinyl-L-Glutamyl-L-Lysine) Hexamethylenediamide (GK-2) |
|
Blynskaya E., Tishkov S., Alekseev K., Minaev S.
|
卷 49, 编号 11 (2016) |
Modern Approaches to Estimating the Content of Genotoxic Impurities in Drugs (a Review) |
|
Matveeva O., Kovaleva E.
|
卷 49, 编号 11 (2016) |
Modern Approaches to the Development of Reference Standards for Quality Assessment of Drug Substances |
|
Merkulov V., Sakanyan E., Klimov V., Shemeryankina T., Yashkir V., Barmin A.
|
卷 53, 编号 6 (2019) |
Modern Extraction Methods for Medicinal Plant Raw Material (Review) |
|
Belokurov S., Narkevich I., Flisyuk E., Kaukhova I., Aroyan M.
|
卷 50, 编号 2 (2016) |
Modern Methods of Analysis of Carotenoids (Review) |
|
Finkel’shtein E.
|
卷 53, 编号 6 (2019) |
Modern Preservatives of Microbiological Stability (Review) |
|
Anurova M., Bakhrushina E., Demina N., Panteleeva E.
|
卷 49, 编号 11 (2016) |
Modern Technologies for Synthesizing Drug Substances: Toward Highly Efficient Drug Production |
|
Narkevich I., Tarasov I., Golant Z., Alekhin A.
|
卷 51, 编号 7 (2017) |
Modification of the Antitumor Action of Cytostatic Drugs Using a Copolymer of N-Vinylpyrrolidone and 2-Methyl-5-Vinylpyridine |
|
Panov A., Kochkina Y., Yartsev E., Eremin D., Yakovleva T., Kedik S.
|
卷 52, 编号 10 (2019) |
Modification of the Benzene Moiety in the Quinolone Nucleus of 4-Hydroxy-6,7-Dimethoxy-2-Oxo-N-(Pyridin-3-Ylmethyl)-1,2-Dihydroquinoline-3-Carboxamide as an Attempt to Enhance its Analgesic Activity |
|
Ukrainets I., Mospanova E., Bereznyakova N., Davidenko A.
|
卷 52, 编号 6 (2018) |
Modified Poly(T-Butyl Methacrylate) as a Doxorubicin Carrier for Targeted Delivery |
|
Zhukova O., Sergeeva T., Gavrina A.
|
卷 52, 编号 5 (2018) |
Molecular-Docking Study of the Interaction of Anti-Inflammatory N-Aroyl-Substituted Halo(H)Anthranilic Acid Amides and Hydrazides with Cyclooxygenase 1 |
|
Andryukov K., Korkodinova L.
|
卷 49, 编号 11 (2016) |
Multi-Day Monitoring of Ubidecarenone Level in Rat Plasma and Tissues After a Single Intravenous Injection |
|
Kalenikova E., Gorodetskaya E., Tokareva O., Belousova M., Kulyak O., Artem’eva M., Medvedev O.
|
卷 52, 编号 1 (2018) |
Multidrug Resistance Reversal Activity of Some New Dihydropyridines Studied by IN SITU Single-Pass Intestinal Perfusion (SPIP) Method in Rat |
|
Sirisha K., Achaiah G., Prasad N., Bhasker S., Umachander L., Malla Reddy V.
|
卷 53, 编号 3 (2019) |
Natural Deep Eutectic Solvents as Alternatives for Extracting Phlorotannins from Brown Algae |
|
Obluchinskaya E., Daurtseva A., Pozharitskaya O., Flisyuk E., Shikov A.
|
卷 50, 编号 2 (2016) |
Near-Infrared Spectroscopy for the Analysis of Solid Dosage Forms: Does the Shell Influence Drug Identification Results? |
|
Gurzhieva A., Elizarova T., Morozova M.
|
卷 52, 编号 5 (2018) |
New 3-(4-Propoxybenzyl)-5-Sulfanyl-Substituted (4H)-1,2,4-Triazoles and Their Antitumor Activity |
|
Ovsepyan T., Dilanyan S., Arsenyan F., Muradyan R., Minasyan N., Melik-Ohanjanyan R.
|
卷 50, 编号 2 (2016) |
New Antiradical Clusters Synthesized Using the First Green Biginelli Reactions of Calix[4]Arene |
|
Pur F., Dilmaghani K.
|
卷 51, 编号 2 (2017) |
New Flavonoids from Serratula coronata L. |
|
Myagchilov A., Sokolova L., Gorovoi P., Dmitrenok P.
|
卷 53, 编号 8 (2019) |
New Formulation Technique for Solubility and Dissolution Rate Enhancement of Poorly Soluble Drugs |
|
Harmalkar D., Godinho S., Bhide P., Kumar L., Shirodkar R.
|
卷 52, 编号 6 (2018) |
New Herbal Preparation Pancafit and Its Anti-Inflammatory Efficacy |
|
Kornopol’tseva T., Botoeva E., Aseeva T., Zhashinamzhilov Z.
|
卷 50, 编号 9 (2016) |
New Synthesis and Analgesic and Diuretic Activity of Halo-Substituted 4-Hydroxy-1-Methyl-2,2-Dioxo- 1H-2λ6,1-Benzothiazine-3-Carboxanilides |
|
Ukrainets I., Petrushova L., Dzyubenko S., Grinevich L.
|
卷 50, 编号 11 (2017) |
New Synthetic Methods for Pyrazolesulfonyl Chlorides as Drug Precursors |
|
Stepanov V., Matyukhin A., Akkuzin K.
|
卷 50, 编号 2 (2016) |
NMR Study of the Phenolic Component Composition of Plant Metabolomes |
|
Anufrieva V., Tolkachev O., Dyumaev K., Sokol’skaya T., Sheichenko V., Sheichenko O.
|
卷 50, 编号 3 (2016) |
Novel Armed Pyrazolobenzothiazine Derivatives: Synthesis, X-Ray Crystal Structure and POM analyses of Biological Activity Against Drug Resistant Clinical Isolate of Staphylococcus aureus |
|
Sajid Z., Ahmad M., Aslam S., Ashfaq U., Zahoor A., Saddique F., Parvez M., Hameed A., Sultan S., Zgou H., Hadda T.
|
卷 51, 编号 12 (2018) |
Novel Free-Radical Scavengers Based on Ferrofluid/Polyaniline Nanocomposites |
|
Pur F., Arsalani N., Safa K.
|
卷 50, 编号 8 (2016) |
Novel Pyrrolo[1,2-a]Pyrazines (TSPO Ligands) with Anxiolytic Activity Dependent on Neurosteroid Biosynthesis |
|
Yarkova M., Mokrov G., Gudasheva T., Seredenin S.
|
卷 53, 编号 3 (2019) |
N-Pyridyl-Substituted Carboxypiperidine Amides: A New Class of Prokaryote Translation Inhibitors |
|
Ivanenkov Y., Komarova (Andreyanova) E., Osterman I., Sergiev P., Yamidanov R., Deineka E., Terent’ev V., Fil’kov G., Sofronova A., Mazhuga A., Dontsova O.
|
卷 50, 编号 7 (2016) |
Olivomycin A – an Antitumor Antibiotic of the Aureolic Acid Group (Review) |
|
Tevyashova A.
|
卷 53, 编号 9 (2019) |
On Secondary Patenting of Organic Compounds Suitable for use as Active Pharmaceutical Ingredients |
|
Chernobrovkin M., Korlyukov A., Suponitskii K., Sinel’nikov A., Goizman M., Shimanovskii N., Zotova O., Ryzhkov I., Popova A.
|
卷 50, 编号 1 (2016) |
Opioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs |
|
Grechko O., Spasov A., Shtareva D.
|
卷 52, 编号 3 (2018) |
Optimization of Culture Conditions for the Production of Lovastatin by Aspergillus Terreus in Submerged Fermentation |
|
Azeem M., Saleem Y., Hussain Z., Zahoor S., Javed M.
|
卷 51, 编号 8 (2017) |
Optimization of Drug Administration Dosage Regimen Considering Chronorhythms and Desynchronosis of Gastrointestinal-Tract Organs |
|
Bunyatyan N., Drogovoz S., Kononenko A., Olefir Y., Prokof’ev A.
|
卷 52, 编号 7 (2018) |
Optimization of Phenazepam Production Technology |
|
Lukashov O., Kazakov P., Mirzabekova N.
|
卷 51, 编号 5 (2017) |
Optimization of (Poly)Hydroxynaphthoquinone Extraction from Shells of Strongylocentrotus Droebachiensis Sea Urchins |
|
Krishtopina A., Urakova I., Pozharitskaya O., Razboeva E., Kosman V., Makarov V., Shikov A.
|
卷 51, 编号 7 (2017) |
Optimization of the Conditions for Assay of Glutamic Acid by Thin Layer Chromatography |
|
Trineeva O., Slivkin A., Safonova E.
|
卷 52, 编号 8 (2018) |
Optimization of the First Step of Enoxaparin Synthesis by Hydrolytic Depolymerization of Unfractionated Heparin |
|
Frumin L., Yur’eva K., Askretkov A., Prokhorov D., Matveev A., Zhavoronok E., Panov A., Shatalov D., Shnyak E., Kedik S.
|
卷 51, 编号 3 (2017) |
Organic Hydrogen Sulfide Donor Compounds with Cardioprotective Properties (Review) |
|
Tkacheva N., Morozov S., Lomivorotov B., Grigor’ev I.
|
卷 50, 编号 3 (2016) |
Oxidative Bromination of O-Xylene |
|
Kazakov P., Gorelenko S., Morozova O., Derevyagina I., Lukashov O., Mirzabekova N.
|
卷 50, 编号 5 (2016) |
Peptide Derivatives of 1,2-Dihydro-3-Methyl-2-Oxoquinoxaline-6-Carboxylic Acid: Synthesis and Evaluation of Antimicrobial, Antifungal and Antiviral Potential |
|
Chaudhary S., Kumar S., Tarazi H.
|
卷 50, 编号 6 (2016) |
Pharmaceuticals for Binary Radiotherapy and Their Use for Treatment of Malignancies (A Review) |
|
Kulakov V., Lipengol’ts A., Grigor’eva E., Shimanovskii N.
|
301 - 400 的 749 信息 |
<< < 1 2 3 4 5 6 7 8 > >> |